Dr. Anna Pevzner-Kalika, DO

Dr. Pevzner-Kalika practices at Cape Fear Valley Betsy Johnson Hospital in Dunn, North Carolina, part of Cape Fear Valley Health.

Dr. Pevzner-Kalika's NPI, 1730328816, was assigned on February 12, 2009. Dr. Pevzner-Kalika holds North Carolina license 2011-00171.

Dr. Pevzner-Kalika's primary practice is Cape Fear Valley Betsy Johnson Hospital, at 800 Tilghman Dr, Dunn, NC 28334 in Harnett County. The practice phone is (910) 892-7161.

Dr. Pevzner-Kalika's primary practice is Cape Fear Valley Betsy Johnson Hospital in Dunn, North Carolina, part of Cape Fear Valley Health. Dr. Pevzner-Kalika is also affiliated with Haywood Regional Medical Center. The medical group on file is Southeastern Emergency Physicians. Dmand AI also links Dr. Pevzner-Kalika to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pevzner-Kalika practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Pevzner-Kalika's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Pevzner-Kalika is licensed in North Carolina.

CMS data shows 375 Medicare services from Dr. Pevzner-Kalika across 4 procedure codes in 2024, for 277 Medicare patients. Medicare paid $29,710 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Pevzner-Kalika in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pevzner-Kalika's median patient age at 60, with 59% women.

In 2024, Dr. Pevzner-Kalika wrote 390 Medicare Part D claims for 238 patients. 95% of them were for generic drugs. CMS names the drug for 186 of them, across 8 drugs with 11 or more claims each, at $1,344 in total drug cost. In 2023, CMS named 128 claims across 6 drugs.

Dr. Pevzner-Kalika accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Pevzner-Kalika from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $22.